Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford US Growth Trust Regulatory News (USA)

Share Price Information for Baillie Gifford US Growth Trust (USA)

Share Price is delayed by 15 minutes
Get Live Data
366.50    1.50 (0.41%)
Bid:
364.00
Ask:
366.50
Spread: 2.50 (0.687%)
Market Cap: £1.01b
USA Live PriceLast checked at - London Stock Exchange

Intraday Baillie Gifford US Growth Trust Share Chart

Net Asset Value(s)

29 May 2026 11:20

RNS Number : 2684G
Baillie Gifford US Growth Trust PLC
29 May 2026
 

Baillie Gifford US Growth Trust plc (USA)

28 May 2026

Legal Entity Identifier : 213800UM1OUWXZPKE539

 

 

Cum Par NAV

332.78p

 

 

 

Ex Par NAV

335.05p

 

 

 

 

Short-term borrowings are valued at par.

 

 

 

Net Asset Values are unaudited, and calculated in accordance with published accounting policies and AIC guidelines.

 

 

 

Cum Par NAV: Net asset value per share in pence, including income, with debt at par value.

Ex Par NAV: Net asset value per share in pence, excluding income, with debt at par value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBGGDUCBDDGLC
Date   Source Headline
7th Apr 202611:27 amRNSNet Asset Value(s)
7th Apr 202610:09 amRNSNet Asset Value(s)
1st Apr 20264:28 pmRNSUpdate on NAV and SpaceX valuation
1st Apr 20264:20 pmRNSNet Asset Value(s)
31st Mar 20261:14 pmRNSNet Asset Value(s)
30th Mar 202612:20 pmRNSNet Asset Value(s)
27th Mar 202611:53 amRNSNet Asset Value(s)
26th Mar 202612:15 pmRNSNet Asset Value(s)
25th Mar 202612:19 pmRNSNet Asset Value(s)
24th Mar 202611:55 amRNSNet Asset Value(s)
23rd Mar 202612:30 pmRNSNet Asset Value(s)
20th Mar 202611:49 amRNSNet Asset Value(s)
19th Mar 202612:56 pmRNSNet Asset Value(s)
18th Mar 202612:26 pmRNSNet Asset Value(s)
17th Mar 202611:37 amRNSNet Asset Value(s)
16th Mar 20263:51 pmRNSHolding(s) in Company
16th Mar 20263:51 pmRNSHolding(s) in Company
16th Mar 202612:55 pmRNSNet Asset Value(s)
13th Mar 202611:56 amRNSNet Asset Value(s)
11th Mar 202611:10 amRNSNet Asset Value(s)
9th Mar 202611:16 amRNSNet Asset Value(s)
6th Mar 202611:27 amRNSNet Asset Value(s)
5th Mar 202612:12 pmRNSNet Asset Value(s)
4th Mar 202611:58 amRNSNet Asset Value(s)
3rd Mar 202612:14 pmRNSNet Asset Value(s)
2nd Mar 20261:40 pmRNSNet Asset Value(s)
27th Feb 20261:06 pmRNSNet Asset Value(s)
26th Feb 202611:42 amRNSNet Asset Value(s)
25th Feb 202611:20 amRNSNet Asset Value(s)
25th Feb 20269:33 amRNSHolding(s) in Company
24th Feb 202611:36 amRNSNet Asset Value(s)
23rd Feb 20261:08 pmRNSNet Asset Value(s)
20th Feb 202611:12 amRNSNet Asset Value(s)
19th Feb 202611:26 amRNSNet Asset Value(s)
19th Feb 20267:50 amRNS-RQuotedData's In The HotSeat
18th Feb 202612:06 pmRNSNet Asset Value(s)
17th Feb 202611:30 amRNSNet Asset Value(s)
16th Feb 202611:32 amRNSNet Asset Value(s)
13th Feb 202612:50 pmRNSNet Asset Value(s)
12th Feb 202611:43 amRNSNet Asset Value(s)
11th Feb 202611:30 amRNSNet Asset Value(s)
10th Feb 202612:35 pmRNSNet Asset Value(s)
9th Feb 202612:36 pmRNSNet Asset Value(s)
6th Feb 202611:39 amRNSNet Asset Value(s)
5th Feb 202611:40 amRNSNet Asset Value(s)
4th Feb 20264:11 pmRNSHolding(s) in Company
4th Feb 202611:50 amRNSHolding(s) in Company
4th Feb 202611:22 amRNSNet Asset Value(s)
3rd Feb 202611:25 amRNSNet Asset Value(s)
2nd Feb 20263:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.